Host cell-dependent replication of HIV-1 gag MA, CA, and NC mutants are independent of the functions of Vif and Vpu

International Journal of Molecular Medicine

Volumn 3, Issue 1, 1999, Pages 91-94

  Shimano, Reika ^a   Inubushi, Ritsuko ^a   Adachi, Akio ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Gag; Human immunodeficiency virus type 1; Vif; Vpu

Indexed keywords

CAPSID PROTEIN; GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; HYBRID PROTEIN; MATRIX PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1; NCP7 PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; VIF PROTEIN; VIRUS PROTEIN; VPU PROTEIN;

ARTICLE; CELL CULTURE; CELL LINE; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MUTATION; PATHOGENICITY; PHYSIOLOGY; VIROLOGY; VIRUS CAPSID; VIRUS REPLICATION;

CAPSID; CAPSID PROTEINS; CELL LINE; GENE PRODUCTS, GAG; GENE PRODUCTS, VIF; GENE PRODUCTS, VPU; HIV ANTIGENS; HIV CORE PROTEIN P24; HIV-1; HUMANS; MUTATION; RECOMBINANT FUSION PROTEINS; TUMOR CELLS, CULTURED; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 0032608619     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.3.1.91     Document Type: Article

References (22)

1. Levy JA: Pathogecnesis of human immunodeficiency virus infection. Microbiol Rev 57: 183-289, 1993.
2. Trono D: HIV accessory proteins: leading roles for supporting cast. Cell 82: 189-192, 1995.
3. Henderson LE, Bowers MA, Sowder RC II, Serabyn SA, Johnson DC, Bess JW, Arthur LO, Bryant DK and Fenselau C: Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: posttranslational modifications, proteolytic proccssincs, and complete amino acid sequences. J Virol 66: 1856-1865, 1992.
4. Wang C-T and Barklis E: Assembly, processing, and infectivity of human immunodeficiency virus type 1 gag mutants. J Virol 67: 4264-4273, 1993.
5. Reicin AS, Paik S, Berkowitz RD, Luban J, Lowy I and Goff SP: Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity. J Virol 69: 642-650, 1995.
6. Kawamura M, Shimano R, Inubushi R, Amano K, Ogasawara T, Akari H and Adachi A: Functional domain mapping of H1V-1 Gag proteins. Biochem Biophys Res Commun 241: 317-320, 1997.
7. Kawamura M, Shimano R, Inubushi R, Akari H and Adachi A: Early function of HIV-1 Gag proteins is cell-dependent. Biochem Biophys Res Commun 248: 899-903, 1998.
8. + T lymphocytes. J Virol 66: 6489-6495, 1992.
9. Sakai H, Shibata R, Sakuragi J, Sakuragi S, Kawamura M and Adachi A: Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles. J Virol 67: 1663-1666, 1993.
10. Sakai H, Tokunaga K, Kawamura M and Adachi A: Function of human immunodeficiency virus type 1 Vpu protein in various cell types. J Gen Virol 76: 2717-2722, 1995.
11. Folks T, Benn S, Rabson A, Theodore T, Hoggan MD, Martin M, Lightfoote M and Sell K: Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immune deficiency syndrome (AIDS)-associated retrovirus. Proc Natl Acad Sci USA 82: 4539-4543, 1985.
12. + cell line H9. AIDS Res Hum Retroviruses 5: 253-255, 1989.
13. Shibata R, Kawamura M, Sakai H, Hayami M, Ishimoto A and Adachi A: Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells. J Virol 65: 3514-3520, 1991.
14. Adachi A,.GendeIman HE, Koenig S, Folks T, Willey R, Rabson A and Martin MA: Production of acquired immunodeficiency syndrome-associated retrovirus in human and non-human cells transfected with an infectious molecular clone. J Virol 59: 284-291, 1986.
15. Willey RL, Smith DH, Laskey LA, Theodore TS, Earl PL, Moss B, Capon DJ and Martin MA: In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J Virol 62: 139-147, 1988.
16. Furuta RA, Shimano R, Ogasawara T, Inubushi R, Amano K, Akari H, Hatanaka M, Kawamura M and Adachi A: HIV-1 capsid mutants inhibit the replication of wild-type virus at both early and late infection phases. FEBS Lett 415: 231-234, 1997.
17. Shimano R, Inubushi R, Fukumori T, Tamaki M, Oshima Y, Kawamura M and Adachi A: Suppression of HIV-2 replication by HIV-l gag mutants. Biochem Biophys Res Commun 248: 418-421, 1998.
18. Adachi A, Ono N, Sakai H, Ogawa K, Shibata R, Kiyomasu T, Masuike M and Ueda S: Generation and characterization of the human immunodeficiency virus type 1 mutants. Arch Virol 117: 45-58, 1991.
19. Kawamura M, Ishizaki T, Ishimoto A, Shioda T, Kitamura T and Adachi A: Growth ability of human immunodeficiency virus type 1 auxiliary gene mutants in primary blood macrophace cultures. J Gen Virol 75: 2427-2431, 1994.
20. Tokunaga K, Ishimoto A, Ikuta K and Adachi A: Growth ability of auxiliary gene mutants of human immunodeficiency virus types 1 and 2 in unstimulated peripheral blood mononuclear cells. Arch Virol 142: 177-181, 1997.
21. Bouyac M, Courcoul M, Bertoia G, Baudat Y, Gabuzda D, Blanc D, Chazal N, Boulanger P, Sire J, Vigne R and Spire B: Human immunodeficiency virus type 1 Vif protein binds to the Pr55 Gag precursor. J Virol 71: 9358-9365, 1997.
22. Callahan MA, Handley MA, Lee Y-H, Talbot KJ, Harper JW and Panganiban AT: Functional interaction of human immunodeficiency virus type 1 Vpu and Gag with a novel member of the tctratricopeptide repeat protein family. J Virol 72: 5189-5197, 1998.